13:00 - 13:30  STC Opening Remarks     
13:30 - 13:55  The biologic mechanisms and pathophysiology of cholestasis
13:55 - 14:20  Adult presentations of "pediatric" genetic cholestatic diseases
14:20 - 14:45  Ductal plate malformations and ciliopathies: a primer for all!
14:45 - 15:10  New and emerging therapies in cholestatic liver disease 
15:10 - 15:30  Round Table & Q&A

16:00 - 16:20  Primer on primary biliary cholangitis: biology and presentation
16:20 - 16:40  Session IV    New therapies for primary biliary cholangitis
16:40 - 17:00  Primary sclerosing cholangitis: where do we stand in the adult world
17:00 - 17:20  Unique pediatric aspects in primary sclerosing cholangitis
17:20 - 17:40  Session IV    Autoimmune hepatitis : what treatment gaps remain?
17:40 - 18:00  Q&A

8:00 - 8:20    Session V    "Overlap" syndromes: real or imaginary?
8:20 - 8:40    Session V    Steroid minimization in childhood autoimmune liver disease
8:40 - 9:00    Session V    Microbiome manipulation and GI-Liver disease
9:00 - 9:20    Treatment and management options in intrahepatic cholestasis of pregnancy 
9:20 - 9:40    Transition of hepatology patients from pediatric to adult care 
9:40 - 10:00  Q&A     

10:30 - 10:50    Cystic fibrosis liver disease in the era of Trikafta
10:50 - 11:10    Alpha-1 antitrypsin deficiency: will molecular therapy change outcomes?
11:10 - 11:30    Hepatitis Delta: entering a new era
11:30 - 11:50    IgG4 disease: from the lens of Rheumatology to the GI
11:50 - 12:10    Biliary atresia: etiology and treatment
12:10 - 12:30    Q&A